| http://www.w3.org/ns/prov#value | - For additional information on Incyte, visit the Company's web site at www.incyte.com.Forward-Looking StatementsExcept for the historical information contained herein, the matters set forth in this press release, including statements regarding the positive results seen in the two pivotal trials COMFORT-I and COMFORT-II supporting ruxolitinib as an important advance for patients with myelofibrosis f
|
